Brief: DiaMedica Therapeutics Announces Full Year 2022 Results
28/03/2023 21:36
March 28 (Reuters) - DiaMedica Therapeutics Inc
DMAC.O :
* DIAMEDICA THERAPEUTICS PROVIDES A BUSINESS UPDATE AND
ANNOUNCES
FULL YEAR 2022 FINANCIAL RESULTS
* DIAMEDICA THERAPEUTICS INC-CASH RUNWAY INTO Q4 2024
Source text for Eikon: ID:nBw4BCRqsa
Further company coverage: DMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program